Update
Teva to Sell Californian Plant as Part of Cost-Cutting Initiative
Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.
Update
Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.
As part of wider R&D cuts, Pfizer will close its clinical research unit in Singapore later this year and lay off about 30 employees.
More flexible regulations on the path for approving potential Alzheimer's disease treatments represent a huge opportunity, according to the US FDA, CROs and research advocates.
Bend Research says collaboration between the Swedish MPA and the US FDA was the reasoning in pursuing GMP from the European body.
The FDA and Health Canada recently opened for industry comment new guidance from the International Conference on Harmonisation on the photosafety testing of drug compounds.